The Psychedelic Businesses Association

Newsroom

Members in The News

News Item — May 20, 2022

PharmaTher Announces Grant of U.S. Patent on Formulation and Production Process of Ketamine and Ketamine Analogs

Read

News Item — May 16, 2022

Ketamine Clinic in Kelowna

Read

News Item — May 12, 2022

Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain

Read

News Item — May 12, 2022

SABI Mind and Reverie Psychedelics Partner To Expand Research Into Psychedelic-Assisted Therapies

Read

News Item — May 12, 2022

Psygen Receives Dealer's Licence from Health Canada

Read

News Item — May 12, 2022

PharmAla Biotech Expands MDMA Distribution with CCrest Labs

Read

Press Releases

Press Release — Sep. 21, 2022

Canadian Psychedelics Industry Tells Policy Makers: Make Room for Healthcare Innovation

Read

Press Release — Aug. 19, 2022

Globe and Mail: 'Fundamental value' in psychedelics remains despite market downturn

Read

Press Release — Jun. 03, 2022

PSYCHEDELICS CANADA APPLAUDS HEALTH CANADA AND BC GOVERNMENT DECISION TO DECRIMINALIZE POSESSION OF SMALL AMOUNTS OF DRUGS

Read

Press Release — May 27, 2022

PSYCHEDELICS CANADA ANNOUNCES THE LAUNCH OF THE FIRST NATIONAL TRADE ASSOCIATION FOR LEGAL PSYCHEDELICS COMPANIES

Read

Media Inquiries